1 mL BAC
10 units
resulting U-100 draw
- Concentration
- 5 mg/mL
- BAC added
- 1 mL
SingleApproved OtherMixedLow confidenceSourced
Sermorelin
A short growth-hormone-releasing hormone analogue with historical diagnostic and paediatric clinical use. Current research products may not match former medicines.
Evidence context, not a personal protocol
Quantities below reproduce their stated source context—label, human study, laboratory work or educational guide. They do not assess suitability, product equivalence or individual risk.
Community-reported schedule
Community-reported · not a validated scheduleCommunity dose schedule
Two community-provenance subcutaneous lines - a curated forum nightly range and an educational 5 mg-vial titration. Community reports only, not a validated or trial-verified schedule.
Reported maximum quantityChoose the maximum quantity reported by this community line. Any earlier phase can be selected below for its arithmetic.
Reported quantities by phase
Select a point for its calculation examples- Nightly (3-6 month cycle)500 mcgCurated forum guidance spans roughly 200-500 mcg per nightly dose; cycles run about 3-6 months before a break.
Vial-aware arithmetic
Reconstitution examples, up to 3 mL
Choose the vial quantity and BAC water first. The diagram and results below update for the selected 500 mcg reported quantity. Higher-strength vials may naturally land outside the 20-30 unit band.
BAC water selected
2 mL
Basic example limit: 3 mL maximum. Check the actual vial and product-specific limits.
U-100 draw20 U
20-30 U reference band
2 mL BAC
20 units
resulting U-100 draw
- Concentration
- 2.5 mg/mL
- BAC added
- 2 mL
Shown in the diagram. Closest of these examples to 25 units.
3 mL BAC
30 units
resulting U-100 draw
- Concentration
- 1.667 mg/mL
- BAC added
- 3 mL
Formula: draw units = selected mg × BAC mL ÷ vial mg × 100. The 20-30 unit band is a measurement reference, not a recommendation. Results are mathematical examples, not preparation instructions.
Dosage and protocol evidence
Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.
Community GuideSubcutaneous in guideNightly
Third-party educational schedule for a 5 mg research vial
200 mcg nightly in weeks 1-2, 300 mcg in weeks 3-4, 400 mcg in weeks 5-6 and 500 mcg in weeks 7-8
The schedule reflects community and historical practice, not a current matched product label. Former paediatric medicines do not establish equivalence for research vials.
View sourceCommunity GuideSubcutaneous in reportsNightly; cycle not validated
online research community summaries and reports
The spotlight states 200-500 mcg subcutaneously before bed, commonly for 3-6 months followed by a break
The channel also records 300 mcg increasing to 500 mcg nightly and provider escalation to 1 mg after poor response. Adult studies cited there used still different 1-2 mg schedules; raw/peptide-education/pe-sermorelin.md:19-21, 42-58 and 217-290.
View sourceCommunity GuideSubcutaneous in reportsNightly; 3-6 month cycles
authenticated research-forum (Peppys) reports and a curated category guide
A curated forum guide describes 200-500 mcg subcutaneously per dose, usually before bed, in 3-6 month cycles; a separate vendor chart lists 300 mcg from a 9 mg vial or 500 mcg from a 15 mg vial nightly for 30 days
Forum provenance from an authenticated archive with usernames omitted. The concrete numbers come from a curated category document and a vendor dosing chart rather than isolated subject reports, and combination threads with ipamorelin do not isolate a sermorelin-only quantity.
View sourceEvidence summary
A short growth-hormone-releasing hormone analogue with historical diagnostic and paediatric clinical use. Current research products may not match former medicines.
Protocol basis
The evidence base contains historical diagnostic and therapeutic protocols, but product availability and formulation identity have changed. A current universal schedule is not supportable.
Community provenance (Peppys)
An authenticated research-forum archive discusses sermorelin mostly for growth-hormone support alongside GLP-1 weight loss, with a curated category guide giving roughly 200-500 mcg subcutaneously before bed in 3-6 month cycles and a vendor chart listing 300-500 mcg nightly for 30 days. Most subject reports describe ipamorelin and sermorelin combinations without isolating a sermorelin-only amount, and the archive frames the numbers as community provenance rather than validated dosing. Usernames and post numbers are omitted. The planner above reproduces the arithmetic of these reported quantities; it does not validate them.
What remains uncertain
Equivalence to former labelled products, adult wellness benefit, optimal monitoring and long-term safety remain uncertain.
Warnings and contraindications
Historical authorised formulations do not automatically validate current research vials.
Use in growth disorders relied on diagnosis, growth monitoring and endocrine laboratory testing.
Growth hormone and IGF-1 effects carry systemic metabolic risks.
Shared across protocols
Supplies and general handling
Keep the universal checklist short. Product-specific labelling and source documentation always take priority over a general guide.
Research vial
Select the labelled vial quantity used in the calculation.
View Peppys vialBacteriostatic water
Use only a diluent appropriate to the research method and formulation.
View Peppys BAC waterU-100 measuring syringe
Use a new sterile device for every entry. Source locally.
Source locallyWipes and sharps container
Plan clean handling and immediate sharps disposal. Source locally.
Source locallyStorage follows the label
Do not apply a universal refrigerator rule. Follow the product, diluent and study documentation for temperature, light and expiry.
Use sterile equipment once
CDC injection-safety guidance calls for a new sterile needle and syringe for each injection and entry into a medication container.
Stability is formulation-specific
Do not infer a post-mixing lifetime from BAC water alone. Discard material when identity, integrity or sterility is in doubt.